ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
53 |
10K |
29 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
53
|
10K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
53 |
10K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
53
|
10K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
53 |
10K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
53
|
10K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
53 |
10K |
30 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
53
|
10K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
53 |
10K |
27 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
53
|
10K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
53 |
10K |
31 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
53
|
10K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
53 |
10K |
80 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
53
|
10K
|
80
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
10K |
3.7M |
26 |
16/04/24 |
16/04/24 |
General
|
10K
|
3.7M
|
26
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
10K |
3.7M |
44 |
16/04/24 |
16/04/24 |
General
|
10K
|
3.7M
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
412 |
112K |
69 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
412
|
112K
|
69
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
412 |
112K |
37 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
412
|
112K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
821 |
206K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
821
|
206K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
821 |
206K |
37 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
821
|
206K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Welcome All
|
|
RaceOncology
|
37 |
14K |
20 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
37
|
14K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
821 |
206K |
19 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
821
|
206K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
412 |
112K |
9 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
412
|
112K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
RaceOncology
|
821 |
206K |
10 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
821
|
206K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Welcome All
|
|
RaceOncology
|
37 |
14K |
34 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
37
|
14K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
412 |
112K |
39 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
412
|
112K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Welcome All
|
|
RaceOncology
|
37 |
14K |
107 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
37
|
14K
|
107
|
|
ASX - By Stock
|
RAC |
Re:
Welcome All
|
|
RaceOncology
|
37 |
14K |
94 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
37
|
14K
|
94
|
|
ASX - By Stock
|
RAC |
Re:
Welcome All
|
|
RaceOncology
|
37 |
14K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
37
|
14K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Welcome All
|
|
RaceOncology
|
37 |
14K |
51 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
37
|
14K
|
51
|
|
ASX - By Stock
|
RAC |
Welcome All
|
|
RaceOncology
|
37 |
14K |
127 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
37
|
14K
|
127
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
68 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
68
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
58 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
33 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
45 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
82 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
82
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
87 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
87
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
36 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
85 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
85
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
RaceOncology
|
76 |
26K |
35 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
RaceOncology
|
2.8K |
976K |
26 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
2.8K
|
976K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
RaceOncology
|
2.8K |
976K |
27 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
2.8K
|
976K
|
27
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
20K |
6.9M |
80 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
80
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
20K |
6.9M |
44 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
44
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
20K |
6.9M |
31 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
31
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
20K |
6.9M |
87 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
87
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
RaceOncology
|
2.8K |
976K |
50 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
2.8K
|
976K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
RaceOncology
|
2.8K |
976K |
100 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
2.8K
|
976K
|
100
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
10K |
3.7M |
107 |
21/01/22 |
21/01/22 |
General
|
10K
|
3.7M
|
107
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
20K |
6.9M |
24 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
24
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
10K |
3.7M |
21 |
21/01/22 |
21/01/22 |
General
|
10K
|
3.7M
|
21
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
10K |
3.7M |
76 |
20/01/22 |
20/01/22 |
General
|
10K
|
3.7M
|
76
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
10K |
3.7M |
56 |
20/01/22 |
20/01/22 |
General
|
10K
|
3.7M
|
56
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
RaceOncology
|
1.6K |
570K |
75 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
1.6K
|
570K
|
75
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in Melanoma preclinical study
|
|
RaceOncology
|
179 |
60K |
21 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
179
|
60K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in Melanoma preclinical study
|
|
RaceOncology
|
179 |
60K |
29 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
179
|
60K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
RaceOncology
|
1.6K |
570K |
6 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
1.6K
|
570K
|
6
|
|